3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
2
Dermatologic
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
73
Carcinoma, Renal Cell
36
Urinary Bladder Neoplasms
25
Carcinoma, Transitional Cell
14
Neoplasm Metastasis
12
Melanoma
12
Ovarian Neoplasms
11
Lung Neoplasms
11
Colorectal Neoplasms
11
Clear-cell metastatic renal cell carcinoma
10
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Wilms Tumor
8
Ureteral Neoplasms
8
Pancreatic Neoplasms
8
Carcinoma, Hepatocellular
8
Lymphoma, Non-Hodgkin
7
Glioma
7
Urethral Neoplasms
6
Sarcoma
6
Neuroblastoma
6
Hepatoblastoma
6
Uterine Cervical Neoplasms
5
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Ependymoma
5
Central Nervous System Neoplasms
5
Interventions
Nivolumab
5
pembrolizumab
4
Ipilimumab
2
Drug Therapy
2
Biopsy
2
poly ICLC
1
pertuzumab
1
osimertinib
1
montanide ISA 51
1
liposomal doxorubicin
1
flt3 ligand protein
1
cobimetinib
1
cemiplimab
1
cc-486
1
brodalumab
1
Trastuzumab
1
Tissue Banks
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Radiotherapy
1
Radiosurgery
1
Quality of Life
1
Psychiatric Rehabilitation
1
Poly I-C
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Specimen Handling
×
Genitourinary
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled